In Beijing, Novo Nordisk's chairman met with China's top trade officials, expressing strong confidence in one of its fastest-growing markets. From diabetes care to new weight-loss treatments, the Danish pharma giant is aligning its strategy with Healthy China 2030 – a national drive to curb chronic diseases and improve public health.